CN Patent

CN108218908A — 一种新型雄激素受体拮抗剂的制备方法

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2018-06-29 · 8y expired

What this patent protects

本发明涉及一种新型雄激素受体拮抗剂的制备方法，该方法主要包括：式V化合物经环合反应得到式VI化合物。该制备方法具有原料易得，原子利用率高、反应条件温和、后处理简便的特点；且通过控制起始原料的立体构型能定向合成ODM‑201及其单一异构体，工艺简单且可控，适合工业化生产。

USPTO Abstract

本发明涉及一种新型雄激素受体拮抗剂的制备方法，该方法主要包括：式V化合物经环合反应得到式VI化合物。该制备方法具有原料易得，原子利用率高、反应条件温和、后处理简便的特点；且通过控制起始原料的立体构型能定向合成ODM‑201及其单一异构体，工艺简单且可控，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108218908A
Jurisdiction
CN
Classification
—
Expires
2018-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Pharmaceutical Industry
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.